Singapore markets closed

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0800-0.0600 (-5.26%)
At close: 04:00PM EDT
1.0800 0.00 (0.00%)
After hours: 07:32PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4545
Avg. Estimate-0.1-0.06-0.28-0.42
Low estimate-0.17-0.14-0.55-0.7
High estimate-0.03-0.01-0.06-0.06
Year ago EPS0.01-0.12-0.54-0.28
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6767
Avg. Estimate10.73M25.91M75.01M56.04M
Low estimateN/A4.4M22.2M21.5M
High estimate45M38M137.3M90.7M
Year ago sales47.6M5.13M60.28M75.01M
Sales growth (year/est)-77.50%405.10%24.40%-25.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.14-0.13-0.12-0.1
Actual EPS0.01-0.12-0.2-0.24
Difference0.150.01-0.08-0.14
Surprise %107.10%7.70%-66.70%-140.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.1-0.06-0.28-0.42
7 days ago-0.13-0.09-0.4-0.42
30 days ago-0.1-0.06-0.27-0.37
60 days ago-0.14-0.14-0.49-0.61
90 days ago-0.14-0.14-0.49-0.61
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesADAPIndustrySector(s)S&P 500
Current qtr.-1,100.00%N/AN/AN/A
Next qtr.50.00%N/AN/AN/A
Current year48.10%N/AN/AN/A
Next year-50.00%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A